EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs

Karina Galčenko, Marilena M Bourdakou, George M Spyrou iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Karina Galčenko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics Department, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Weightlessness, Drug Repositioning, Gene Expression Regulation, Transcriptome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research and Innovation Foundation, European Union through Research and Innovation Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Space exploration has progressed from contemporary discoveries to current endeavors, such as space tourism and Mars missions. As human activity in space accelerates, understanding the physiological effects of microgravity on the human body is becoming increasingly critical. This study analyzes transcriptomic data from human cell lines exposed to microgravity, investigates its effects on gene expression, and identifies potential therapeutic interventions for health challenges posed by spaceflight. Our analysis identified five under-expressed genes (DNPH1, EXOSC5, L3MBTL2, LGALS3BP, SPRYD4) and six over-expressed genes (CSGALNACT2, CSNK2A2, HIPK1, MBNL2, PHF21A, RAP1A), all of which exhibited distinct expression patterns in response to microgravity. Enrichment analysis highlighted significant biological functions influenced by these conditions, while in silico drug repurposing identified potential modulators that could counteract these changes. This study introduces a novel approach to addressing health challenges during space missions by repurposing existing drugs and identifies specific genes and pathways as potential biomarkers for microgravity effects on human health. Our findings represent the first systematic effort to repurpose drugs for spaceflight, establishing a foundation for the development of targeted therapies for astronauts. Future research should aim to validate these findings in authentic space environments and explore broader biological impacts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

WeightlessnessDrug RepositioningGene Expression RegulationTranscriptomeHumansSpace FlightGene Expression ProfilingSignal TransductionCell Line

Stichwörter der Autor:innen

drug repurposinggene expressionmicrogravityspace healthspaceflighttranscriptomics

Autor:innen und Institutionen

  • Bioinformatics Department, The Cyprus Institute of Neurology and Genetics, 2371 Nicosia, Cyprus.

ORCID-Profile: George M Spyrou

Förderung

  • Research and Innovation Foundation
  • European Union through Research and Innovation Foundation

Zitieren

APA

Galčenko, K., Bourdakou, M. M., & Spyrou, G. M. (2025). Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031287

Vancouver

Galčenko K, Bourdakou MM, Spyrou GM. Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031287

BibTeX
@article{Galenko2025,
  author = {Galčenko, Karina and Bourdakou, Marilena M and Spyrou, George M},
  title = {Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031287}
}
Kostenlos starten →